Molecular Pharmacology Program
The Daniel Heller Lab
Research
Professor
Cancer Nanomedicine Laboratory
We are a biomedical engineering laboratory that develops nanotechnologies to advance breakthroughs in the research, diagnosis, and treatment of cancer and allied diseases. We develop drug delivery technologies to target therapies to disease sites, advanced diagnostics to detect disease at earlier stages, and nanosensors to accelerate the discovery of new therapies. Please check out our recent innovations using the “View Lab Overview” button below…
Research Projects
Featured News
Publications Highlights
Highlighted in: MSK News and Nature Materials News & Views
M Kim, C Chen, P Wang, JJ Mulvey, Y Yang, C Wun, M Antman-Passig, H-B Luo, S Cho, K Long-Roche, LV Ramanathan, A Jagota, M Zheng, Y Wang, DA Heller*. “Machine-Learning-Based Detection of an Ovarian Cancer Disease Fingerprint from Serum via Quantum Defect-Modified Carbon Nanotube Arrays.” Nature Biomedical Engineering (2022). https://www.mskcc.org/news/sensor-sniffs-cancer-using-artificial-intelligence
Z Yaari, Y Yang, E Apfelbaum, C Cupo, A Settle, Q Cullen, W Cai, K Long Roche, DA Levine, M Fleisher, L Ramanathan, M Zheng, A Jagota, DA Heller*. ”A Perception-Based Machine-Perception Nanosensor Platform to Detect Cancer Biomarkers.” Science Advances 7 (2021) eabj0852. MSK News: https://www.mskcc.org/news/detect-ovarian-cancer-early-researchers-look-nanotechnology
J Budhathoki-Uprety, J Shah, JA Korsen, AE Wayne, TV Galassi, JR Cohen, JD Harvey, PV Jena, LV Ramanathan, EA Jaimes, DA Heller*. “Synthetic Molecular Recognition Nanosensor Paint for Microalbuminuria.” Nature Communications 10 (2019) 3605.
[MSK News: https://www.mskcc.org/news/science-meets-art-produce-diagnostic-test-us…]
People
Daniel A. Heller, PhD
Member, Molecular Pharmacology Program, SKI
Professor
- Biomedical engineer Daniel Heller is Head of the Cancer Nanotechnology Laboratory, which invents disruptive technologies to revolutionize the diagnosis and treatment of cancer and allied diseases.
- PhD, University of Illinois at Urbana-Champaign
- [email protected]
- Email Address
- 646-888-3419
- Office Phone
- Download CV
- PDF File
Members
- BS in Biomedical Engineering from Tecnologico de Monterrey, Monterrey, Mexico (2023)
- BS in Chemistry from The College of New Jersey, Ewing NJ (2019)
- 646-888-3416
- Lab Phone
- PhD in Engineering and Bioengineering
- PhD in Chemistry
- PhD in Nano Biosensing
- BS in Biochemistry
- PhD, Weill Graduate School of Medical Sciences, Cornell University
- Massachusetts Institute of Technology 2013
- 646-888-3416
- Lab Phone
- PhD in Chemical Engineering
- BS, Cornell University
- BS in Biochemistry from University of Delaware (2014)
- BS in Biology (Cell Molecular and Genetics) from University of Delaware (2014)
- BA in Chemistry
- PhD in Pharmaceutical and Pharmacological Sciences
- BSc in Biochemical Engineering
- MSc in Chemical Engineering
- PhD in Chemical Engineering
Lab Alumni
Lab Affiliations
Achievements
- College of Liberal Arts and Sciences Young Alumni Award, University of Illinois (2024)
- Life Sciences Invention of the Year, UM Ventures (2023)
- American Institute for Medical and Biological Engineering (AIMBE) Fellow (2021)
- Pharmacology Teaching and Mentoring Award, Weill Cornell Graduate School (2020)
- American Cancer Society Research Scholar (2018)
Read more
- NSF CAREER Award (2018)
- Pershing Square Sohn Prize for Young Innovators in Cancer Research (2017)
- NIH Director’s New Innovator Award (2012)
- Damon Runyon Cancer Research Foundation Postdoctoral Fellowship (2010)
- Beckman Institute Graduate Fellowship (2006)
Lab News & Events
Upcoming event
Lipid Nanoparticles for Overcoming Biological Barriers to mRNA Delivery
Memorial Sloan Kettering Cancer Center
Rockefeller Research Laboratories
430 East 67th Street
Room RRL-116
New York, NY 10065
Accolades
Team Recognitions
-
Congratulations to Erin Keblish for winning the 2024 Three Minute Thesis competition!
-
Congratulations to Magdalini Panagiotakopoulos for winning the AI in Drug Delivery award at CRS 2024 Annual Meeting and Expo!
-
Congratulations to Jaina Wollowitz on her poster award at the 245th Electrochemical Society Meeting!
-
Congratulations to Dana Goerzen for being awarded by the Canadian Institutes of Health Research Doctoral Research Award (Funding Number 193220)!
-
Congratulations to Dana Goerzen for being awarded the General Atlantic Graduate Research Fellowship Award!
-
Congratulations to Atena Farahpour - awarded the Fall 2023 NanoBioNYC student award in Biomedical Materials!
-
Congratulations to Dr. Mijin Kim for being selected as a 2023 STAT Wunderkind! The award recognizes the work of early-career scientists and clinicians.
-
Congratulations to Chen Chen on the Best Poster Award at the 19th Annual Tri-institutional Chemical Biology Symposium!
-
Congratulations to Mijin Kim on winning the 2023 MSK Postdoctoral Researcher Award!
-
Congratulations to Dr. Mijin Kim - NIH K99/R00 awardee!
-
Congratulations to Naxhije Berisha - Tow Fellowship Awardee!
-
Congratulations to Dr. Mijin Kim - Kravis WiSE Postdoctoral Fellowship Winner!
-
Congratulations to Stephen Ruiz - awarded the MERIT Mandel Graduate Fellowship!
-
Congratulations to Magdalini Panagiotakopoulos – Tow Postdoctoral Fellowship Awardee!
-
Congratulations to Dr. Mijin Kim – MIT Technology Review 35 Under 35 Innovator!
-
Congratulations to Magdalini Panagiotakopoulos on winning the Controlled Release Society Poster Prize
-
Congratulations to Erin Keblish on winning the 2023 Electrochemical Society Best Poster Award for Industrial/Applied Science
-
Congratulations to Magdalini Panagiotakopoulos for winning 2nd place and the People's Choice Award in the 2023 MSK Postdoc Slam
-
Congratulations to Stephen Ruiz for winning the 63rd International Conference on the Bioscience of Lipids Oral Communication Award!!
-
Congratulations to Mijin Kim for winning the 2023 STAT Wunderkind Award!!
Open Positions
To learn more about available postdoctoral opportunities, please visit our Career Center
To learn more about compensation and benefits for postdoctoral researchers at MSK, please visit Resources for Postdocs
Get in Touch
-
Lab Head Email
-
Office Phone
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Daniel A. Heller discloses the following relationships and financial interests:
-
Celine Therapeutics
Equity; Professional Services and Activities (Uncompensated) -
Concarlo Therapeutics, Inc.
Professional Services and Activities -
Lime Therapeutics, Inc.
Equity; Professional Services and Activities (Uncompensated) -
Mediphage Bioceuticals, Inc.
Equity; Professional Services and Activities (Uncompensated) -
METiS Therapeutics Inc.
Intellectual Property Rights; Professional Services and Activities (Uncompensated)
-
Nanorobotics, Inc.
Equity; Professional Services and Activities (Uncompensated) -
Nine Diagnostics, Inc.
Equity; Fiduciary Role / Position; Professional Services and Activities (Uncompensated) -
Selectin Therapeutics, Inc.
Equity; Professional Services and Activities (Uncompensated) -
Singapore-MIT Alliance for Research and Technology
Professional Services and Activities
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].